Virginia Commonwealth University: Hypertension trials
The registry lists 12 Hypertension studies with Virginia Commonwealth University as lead sponsor. 1 are open to participants now and 2 have results posted.
Phase 1 3Phase 2 2Phase 4 2No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Autonomic and Renal Contributions to Hypertension With ADTRecruitingNCT07848828Phase 4
- Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary HypertensionTerminatedNCT01479010Phase 1/2Results posted
- Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial HypertensionCompletedNCT00964678Phase 1/2Results posted
- Chronobiology of Meal Timing: Effects on Vascular and Renal FunctionCompletedNCT05987566Not applicable
- Improving Adherence to Home Blood Pressure Monitoring With Pharmacist SupportTerminatedNCT04577131Not applicable
- 24-Hour Ambulatory Blood Pressure Monitoring in Community PharmaciesCompletedNCT03920956Not applicable
- Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium IntakeCompletedNCT03558022Not applicable
- Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic SyndromeCompletedNCT03542240Not applicable
- Pilot for a Community Pharmacy Service Model: Impact of a Pharmacist Monitored Patient Blood Pressure ReadingsCompletedNCT03323840Not applicable
- Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial HypertensionCompletedNCT03057028Phase 1
- The Management of Resistant Hypertension in Kidney Transplant Patients Using ChlorthalidoneWithdrawnNCT02030314Phase 4
- Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis CCompletedNCT00252642Not applicable